VALYSTR · Stock research
Listed on NYSE American. What the market is pricing into Actinium Pharmaceuticals, Inc. (ATNM) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $43.9M · P/E 3.9 · revenue $35.1M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows